According to OpenAI via Greg Brockman and the linked OpenAI blog, GPT-Rosalind mapped mouse-brain gene expression in 32 minutes to propose impaired cholesterol transport as a testable mechanism tied to DCTN1 and Perry syndrome, highlighting new neurodegeneration drug targets with PerturbAI and Scripps Research.

According to OpenAI, GPT-Rosalind linked DCTN1 disruption to elevated cholesterol synthesis genes in mouse brain data and proposed impaired cholesterol transport as a testable mechanism for neurodegeneration.